NCT06779851
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06779851
Title A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors (SUMMIT-1)
Acronym SUMMIT-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bright Peak Therapeutics Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Honor Health Research Institute RECRUITING Scottsdale Arizona 85260 United States Details
Start Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Hackensack Meridian John Theurer Cancer Center RECRUITING Hackensack New Jersey 07601 United States Details
Carolina BioOncology Institute RECRUITING Huntersville North Carolina 28078 United States Details
Providence Cancer Institute RECRUITING Portland Oregon 97213 United States Details
University of Pittsburgh Medical Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
South Texas Accelerated Research Therapeutics (START) RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field